Massimo F. Piepoli

Cardiology and Cardiovascular Medicine · 2017

A researcher in the Science corpus: 1 paper; trusts 47 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 87 citations into it; #201 of 906 by trust here, #798 by citations
• Surgery — 50 citations into it
• Endocrinology, Diabetes and Metabolism — 45 citations into it
• Public Health, Environmental and Occupational Health — 26 citations into it; #705 of 2,368 by trust here, #1,951 by citations
• Physiology — 24 citations into it
• Epidemiology — 22 citations into it
• Complementary and alternative medicine — 13 citations into it
• Cancer Research — 11 citations into it

Whom Massimo F. Piepoli trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. Moneta
2. B. J. Gersh
3. R. Shephard
4. K. Grunert
5. C. Vlachopoulos
6. R. Collins
7. L. Moran
8. Virend K. Somers
9. Vaughn Barry
10. Duck-chul Lee

Who trusts Massimo F. Piepoli overall

1. A. Fanouriakis
2. Nikolaos-Renatos Tziolos
3. George Bertsias
4. D. Boumpas

Papers from Massimo F. Piepoli's perspective

Ordered by how strongly the researchers Massimo F. Piepoli trusts endorse each paper. Same corpus, a different order for every researcher.

1. Genetic Risk, Coronary Heart Disease Events, and the Clinical Benefit of Statin Therapy (The Lancet)
2. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
3. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (New England Journal of Medicine)
4. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
5. Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies (Circulation)
6. Cardiovascular fitness, cortical plasticity, and aging. (Proceedings of the National Academy of Sciences of the United States of America)
7. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
8. A review of European research on consumer response to nutrition information on food labels (Journal of public health)
9. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)

Their papers

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017) — 714 citations